News

Pfizer Inc. and Trillium Therapeutics Inc. announced that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium, a clinical stage…
Read More...

Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) approved the Biologics License Application (BLA) for COMIRNATY (COVID-19 Vaccine, mRNA) to prevent…
Read More...

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for Orencia (abatacept) for the…
Read More...

BioDuro-Sundia, a leading drug discovery and development services organization backed by Advent International, announced today it has entered into a definitive agreement to acquire a…
Read More...

Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate, announced that…
Read More...

JW Therapeutics an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy, announced that it has entered into a strategic…
Read More...

BeiGene, Ltd. a global biotechnology company focused on developing and commercializing innovative medicines worldwide, announced that the Center for Drug Evaluation (CDE) of the China…
Read More...

Bristol Myers Squibb announced that Opdivo(nivolumab) 240 mg every two weeks or 480 mg every four weeks (injection for intravenous use) was approved by the U.S. Food and Drug…
Read More...

Bristol Myers Squibb announced that the European Commission (EC) has granted Conditional Marketing Authorization for Abecma (idecabtagene vicleucel; ide-cel), a first-in-class B-cell…
Read More...

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced the launch of its MaxSignal Mycotoxin Automation Bundle. Using the new assays and automation…
Read More...

In draft guidance published today (19 August 2021), NICE has recommended midostaurin (Rydapt, Novartis) as a treatment for advanced systemic mastocytosis in adults. Mastocytosis is a…
Read More...

Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced plans to expand its commercial manufacturing capacity at its Rensselaer, New…
Read More...

Sorrento Therapeutics, Inc. a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19. The publication details preclinical…
Read More...

Alligator Bioscience announced that the company has entered into a research collaboration and license agreement with Orion Corporation, a global pharmaceutical company based in Finland,…
Read More...

NRx Pharmaceuticals (NRx) a clinical stage, biopharmaceutical company provided a safety update on ZYESAMI (aviptadil) which is being tested in the ACTIV-3 Critical Care Phase 3 study…
Read More...

Roche announced U.S. Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel, advancing the company's commitment to personalised healthcare through tests that…
Read More...

Jardiance (empagliflozin) 10 mg has been approved by the U.S. Food and Drug Administration to reduce the risk of cardiovascular death plus hospitalization for heart failure in adults…
Read More...

CM Life Sciences II and SomaLogic, Inc., a leader in AI-data driven proteomics technology, and Twist Bioscience Corporation, a company enabling customers to succeed through its offering…
Read More...

Pfizer Inc. and BioNTech SE announced that they have submitted Phase 1 data to the U.S. Food and Drug Administration (FDA) to support the evaluation of a third, or booster, dose of the…
Read More...

GlaxoSmithKline (GSK) plc announced the US Food and Drug Administration (FDA) approved a new indication for JEMPERLI (dostarlimab-gxly), a programmed cell death receptor-1 (PD-1)…
Read More...